Literature DB >> 23175268

Gamma interferon release assay for monitoring of treatment response for active tuberculosis: an explosion in the spaghetti factory.

Claudia M Denkinger1, Madhukar Pai, Meena Patel, Dick Menzies.   

Abstract

Few studies have correlated the results of interferon (gamma interferon) release assays (IGRAs) with known markers of tuberculosis (TB) treatment response. We report the results of serial QuantiFERON-TB gold in-tube assay (QFT) testing on 149 patients with active tuberculosis and correlate the results with smear and culture conversion. We show that QFT results do not offer much value for treatment monitoring of TB disease.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23175268      PMCID： PMC3553895          DOI： 10.1128/JCM.02278-12

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  11 in total

1.  Counting antigen-specific T cells: a new approach for monitoring response to tuberculosis treatment?

Authors:  Ajit Lalvani
Journal:  Clin Infect Dis       Date:  2004-02-17       Impact factor: 9.079

2.  Within-subject variability of Mycobacterium tuberculosis-specific gamma interferon responses in German health care workers.

Authors:  Felix C Ringshausen; Albert Nienhaus; José Torres Costa; Heiko Knoop; Stephan Schlösser; Gerhard Schultze-Werninghaus; Gernot Rohde
Journal:  Clin Vaccine Immunol       Date:  2011-05-18

3.  Dynamic relationship between IFN-gamma and IL-2 profile of Mycobacterium tuberculosis-specific T cells and antigen load.

Authors:  Kerry A Millington; John A Innes; Sarah Hackforth; Timothy S C Hinks; Jonathan J Deeks; Davinder P S Dosanjh; Valerie Guyot-Revol; Rubamalaar Gunatheesan; Paul Klenerman; Ajit Lalvani
Journal:  J Immunol       Date:  2007-04-15       Impact factor: 5.422

4.  Use of the QuantiFERON-TB Gold In-Tube test to monitor treatment efficacy in active pulmonary tuberculosis.

Authors:  S K Katiyar; A Sampath; S Bihari; M Mamtani; H Kulkarni
Journal:  Int J Tuberc Lung Dis       Date:  2008-10       Impact factor: 2.373

5.  Tuberculosis treatment effect on T-cell interferon-gamma responses to Mycobacterium tuberculosis-specific antigens.

Authors:  C B E Chee; K W KhinMar; S H Gan; T M Barkham; C K Koh; L Shen; Y T Wang
Journal:  Eur Respir J       Date:  2009-11-19       Impact factor: 16.671

6.  Short-term reproducibility of a commercial interferon gamma release assay.

Authors:  A K Detjen; L Loebenberg; H M S Grewal; K Stanley; A Gutschmidt; C Kruger; N Du Plessis; M Kidd; N Beyers; G Walzl; A C Hesseling
Journal:  Clin Vaccine Immunol       Date:  2009-06-17

7.  Interpretation of Mycobacterium tuberculosis antigen-specific IFN-gamma release assays (T-SPOT.TB) and factors that may modulate test results.

Authors:  K Dheda; A Pooran; M Pai; R F Miller; K Lesley; H L Booth; G M Scott; A N Akbar; A Zumla; G A Rook
Journal:  J Infect       Date:  2007-04-19       Impact factor: 6.072

8.  Correlation of mycobacterium tuberculosis specific and non-specific quantitative Th1 T-cell responses with bacillary load in a high burden setting.

Authors:  Grant Theron; Jonny Peter; Laura Lenders; Richard van Zyl-Smit; Richard Meldau; Ureshnie Govender; Keertan Dheda
Journal:  PLoS One       Date:  2012-05-22       Impact factor: 3.240

Review 9.  Within-subject variability of interferon-g assay results for tuberculosis and boosting effect of tuberculin skin testing: a systematic review.

Authors:  Richard N van Zyl-Smit; Alice Zwerling; Keertan Dheda; Madhukar Pai
Journal:  PLoS One       Date:  2009-12-30       Impact factor: 3.240

10.  T-cell assays for tuberculosis infection: deriving cut-offs for conversions using reproducibility data.

Authors:  Anandharaman Veerapathran; Rajnish Joshi; Kalyan Goswami; Sandeep Dogra; Erica E M Moodie; M V R Reddy; Shriprakash Kalantri; Kevin Schwartzman; Marcel A Behr; Dick Menzies; Madhukar Pai
Journal:  PLoS One       Date:  2008-03-26       Impact factor: 3.240
View more
  25 in total

1.  Potential Immunological Biomarkers for Detection of Mycobacterium tuberculosis Infection in a Setting Where M. tuberculosis Is Endemic, Ethiopia.

Authors:  Takele Teklu; Keehwan Kwon; Biniam Wondale; Milkessa HaileMariam; Aboma Zewude; Girmay Medhin; Mengistu Legesse; Rembert Pieper; Gobena Ameni
Journal:  Infect Immun       Date:  2018-03-22       Impact factor: 3.441

2.  Quantification of circulating Mycobacterium tuberculosis antigen peptides allows rapid diagnosis of active disease and treatment monitoring.

Authors:  Chang Liu; Zhen Zhao; Jia Fan; Christopher J Lyon; Hung-Jen Wu; Dobrin Nedelkov; Adrian M Zelazny; Kenneth N Olivier; Lisa H Cazares; Steven M Holland; Edward A Graviss; Ye Hu
Journal:  Proc Natl Acad Sci U S A       Date:  2017-03-27       Impact factor: 11.205

3.  Biomarkers on patient T cells diagnose active tuberculosis and monitor treatment response.

Authors:  Toidi Adekambi; Chris C Ibegbu; Stephanie Cagle; Ameeta S Kalokhe; Yun F Wang; Yijuan Hu; Cheryl L Day; Susan M Ray; Jyothi Rengarajan
Journal:  J Clin Invest       Date:  2015-03-30       Impact factor: 14.808

4.  Interferon-gamma response to the treatment of active pulmonary and extra-pulmonary tuberculosis.

Authors:  L Liang; R Shi; X Liu; X Yuan; S Zheng; G Zhang; W Wang; J Wang; K England; L E Via; Y Cai; L C Goldfeder; L E Dodd; C E Barry; R Y Chen
Journal:  Int J Tuberc Lung Dis       Date:  2017-10-01       Impact factor: 2.373

5.  Post-treatment change in Mycobacterium tuberculosis antigen-stimulated tumor necrosis factor-alpha release in patients with active tuberculosis.

Authors:  Chang Ho Kim; Seung Soo Yoo; Shin Yup Lee; Seung Ick Cha; Jae Yong Park; Jaehee Lee
Journal:  J Thorac Dis       Date:  2015-05       Impact factor: 2.895

Review 6.  Gamma interferon release assays for detection of Mycobacterium tuberculosis infection.

Authors:  Madhukar Pai; Claudia M Denkinger; Sandra V Kik; Molebogeng X Rangaka; Alice Zwerling; Olivia Oxlade; John Z Metcalfe; Adithya Cattamanchi; David W Dowdy; Keertan Dheda; Niaz Banaei
Journal:  Clin Microbiol Rev       Date:  2014-01       Impact factor: 26.132

7.  Prevalence of tuberculosis infection and disease in children referred for tuberculosis medical surveillance in Ontario: a single-cohort study.

Authors:  Catherine Yang; Abdool S Yasseen; Jennifer Stimec; Elizabeth Rea; Valerie Waters; Ray Lam; Shaun K Morris; Ian Kitai
Journal:  CMAJ Open       Date:  2018-08-28

8.  Clinical Evaluation of a Blood Assay to Diagnose Paucibacillary Tuberculosis via Bacterial Antigens.

Authors:  Chang Liu; Christopher J Lyon; Yang Bu; Zaian Deng; Elisabetta Walters; Yan Li; Liqun Zhang; Anneke C Hesseling; Edward A Graviss; Ye Hu
Journal:  Clin Chem       Date:  2018-01-18       Impact factor: 8.327

9.  Serial Interferon-Gamma Release Assay (IGRA) Testing to Monitor Treatment Responses in Cases of Feline Mycobacteriosis.

Authors:  Jordan L Mitchell; Conor O'Halloran; Paul Stanley; Kieran McDonald; Paul Burr; Danièlle A Gunn-Moore; Jayne C Hope
Journal:  Pathogens       Date:  2021-05-26

10.  Repeat IGRA testing in Canadian health workers: conversions or unexplained variability?

Authors:  Alice Zwerling; Andrea Benedetti; Mihaela Cojocariu; Fiona McIntosh; Filomena Pietrangelo; Marcel A Behr; Kevin Schwartzman; Dick Menzies; Madhukar Pai
Journal:  PLoS One       Date:  2013-01-31       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.